Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Eisai describes selective dopamine D3 antagonists

Dec. 16, 1996

Novel anticancer agents from Sankyo

Dec. 16, 1996

Antiallergic/antiasthmatic compounds disclosed by Dainippon Ink

Dec. 16, 1996

Antiinflammatory glycolipid compounds from Nissin Food Products

Dec. 16, 1996

New antitussive agent from Snow Brand Milk Products

Dec. 16, 1996

New antihypertensive agents from Banyu

Dec. 16, 1996

Distamycin analogues claimed by Mitsui Toatsu

Dec. 16, 1996

Antihypertensive peptides disclosed by Snow Brand

Dec. 13, 1996

New immunostimulant from Snow Brand

Dec. 13, 1996

Chugai reports new cholesterol-lowering compounds

Dec. 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...